AACE Position Statements
- American Association of Clinical Endocrinologists (AACE) Position Statement on Hormone Replacement Therapy (HRT) and Cardiovascular Risk
- American Association of Clinical Endocrinologists (AACE) Reproductive Medicine Committee Position Statement on Bioidentical Hormones
- American Association of Clinical Endocrinologists Position Statement on IV Bisphosphonates
- American College of Endocrinology/American Association of Clinical Endocrinologists: Reaffirmation of the 2003 ACE Insulin Resistance Syndrome (IRS) Position Statement
- AACE Position Statement on the Diagnosis and Management of Primary Hyperparathyroidism
- AACE Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome
- AACE, TES, ATA Joint Position Statement on the Use and Interchangeability of Thyroxine Products
- AACE/ATA/TES Joint Statement RE: FDA approval of generic levothyroxine preparations as equivalent to branded preparations
- AACE Statement on Estrogen-alone Arm of WHI
- AACE Statement on Growth Hormone Usage in Short Children
- AACE Statement on WHIMS
- AACE Position: Insulin Resistance Syndrome
- Position Statement on Subclinical Hypothyroidism During Pregnancy
- Position Statement on Subclinical Thyroid Disease
- Obesity Position Statement © 1998
AACE Consensus Conference Position Statements
- Implementation Conference for ACE Outpatient Diabetes Mellitus Consensus Conference Recommendations: Position Statement
- Patient Safety and Medical System Errors in Diabetes and Endocrinology Consensus Conference: Position Statement
- AACE Statement Inpatient Diabetes
- AACE Position: Insulin Resistance Syndrome
- American College of Endocrinology Consensus Statement on Guidelines for Glycemic Control